Key result
Suspending anticoagulants before SCS surgery is not linked to increased perioperative adverse events versus nonusers.
Why the study?
The safety of performing epidural placement or revision of spinal cord stimulation in patients who routinely use anticoagulants but have their anticoagulation held per guidelines was uncertain.
Does temporary suspension of routine anticoagulation prevent adverse events in patients undergoing spinal cord stimulation?
Population
225 patients undergoing SCS lead placement or revision
Comparison
Anticoagulant-suspended patients vs nonanticoagulated patients
Design
Retrospective analysis of a prospectively collected database
Follow-up
90 days
Authors
Loading...
May support anticoagulant suspension before SCS; observational data leaves practice implications open pending RCTs.
Cohort (n=225)
Does temporary suspension of routine anticoagulation prevent adverse events in patients undergoing spinal cord stimulation?
p-value: p=> 0.05
Temporarily holding anticoagulation for spinal cord stimulation surgery does not increase the risk of perioperative hemorrhagic or thromboembolic adverse effects compared to non-anticoagulated patients.
Khan et al. (2017) conducted a cohort in Patients undergoing spinal cord stimulation (SCS) (n=225). Anticoagulant use (suspended per guidelines) vs. No anticoagulants was evaluated on Any adverse event occurring within 90 days after SCS lead placement/revision (p=> 0.05). Suspension of anticoagulants prior to spinal cord stimulation surgery was not associated with an increased risk of perioperative adverse events compared with nonanticoagulated patients (P>0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: